James Lee’s

Biotech Story

How science becomes medicine, and medicine becomes business.Founder, Bridge Biotherapeutics

Chapter I

J.L. Crosses a Bridge

01 / Build

Build.

From science to business. Development strategy, business development and partnering, drawn from founding and running Bridge Biotherapeutics.

02 / Share

Share.

From experience to the next question. Decisions, mistakes and lessons from the field, shared in writing and lectures.

03 / Connect

Connect.

From meeting to possibility. Rooms where people with different experience start talking, and keep going.

People make
possibilities.

Lantern oneKoreaNight @ JPM. The first night for Korean biotech to meet during JPM week.

Lantern twoInnovative Drug Salon, Pangyo. Grown from one room into a national meeting place.

Lantern threeLG alumni, and the biotech CEO circle. Old ties kept warm.

Coming soonSmall gatherings, deep conversations.

Chapter II / J.L. Writes to Shareholders

Records remain.
Thoughts continue.

Letters written to shareholders before the IPO, read again with today’s questions.

BBT Letters2015

BBT Letters2016

BBT Letters2017

BBT Letters2018

BBT Letters2019

ArchiveRead the letters ↗ EssaysJames Blog ↗ LibraryResources ↗

Chapter III

J.L. Is Not Finished

Beta in 2026DD SaaS
From candidate selection to IND and clinical results, evidence and execution in one place.
BetaIR Hub
IR readiness checks for early companies, so the right investors meet.
Coming soonScience Communicator
With VanitasLab, science told precisely on film.
BetaJesus Melody
A practice app for church and cathedral choirs.

A story of

Science, Business, People

In collaboration with

Tinaclon

AI-driven discovery

QuBest Bio

Preclinical development

KCRN

Early clinical development

VanitasLab

Science communication

What’s your
next question?

Biotech business development, advisory, lectures, and the gatherings we could build together.